Gelonghui April 2 丨 Zhenghai Biotech (300653.SZ) was surveyed by specific subjects on April 1, 2024, on “Sales progress of active biological bone products?” The company replied that according to the “National Organization's Centralized Volume Procurement Notice for Artificial Crystals and Sports Medicine Medical Consumables (No. 2)” issued by the Tianjin Pharmaceutical Procurement Center in September 2023, the company's product active biological bone is not within the scope of this collection. The company's active biological bone products have completed the conversion verification process within 2023 and officially launched for sale. Up to now, the Internet connection work has been completed in more than 2/3 provinces, and related marketing work is being actively promoted.
正海生物(300653.SZ)：活性生物骨产品已经于2023年内完成转产验证工作，正式上市销售
Zhenghai Biotech (300653.SZ): Active biological bone products have completed the conversion verification process within 2023 and officially launched for sale
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.